Companies /Healthcare

Pfizer Inc

NYSE: PFE Drug Manufacturers - General
$28.18
▲ $0.25 (+0.90%) today
Markets closed · 1:13am ET

PFE Coverage

Page 101
4:44pm ET
Health and Healthcare

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading.  The company didn’t have another biotech drug crisis though. Biogen had been under a corporate strategic review where it was evaluating strategic…

Douglas A. McIntyre